OVERVIEW

Join the Association of Migraine Disorders and IVPN Neuropsychiatry for a webinar on "CGRP Monoclonal Antibodies: Its Adverse Events and Role in Migraine Prevention" on Friday June 23rd at 12pm ET. Dr. Lawrence Robbins will present on: The Adverse Events of CGRP Monoclonal Antibodies: Why Clinical Trials Miss It? Then, Dr. Alessandro Terruzzi will discuss the Role of Rimegepant in Preventive Therapy During a Migraine Attack.

WEBINAR INFO

Webinar agenda and speakers:

• Welcome and Introduction
• The Adverse Events of CGRP Monoclonal Antibodies: Why Clinical Trials Miss It? - Lawrence Robbins, MD
• The Role of Rimegepant in Preventative Therapy During a Migraine Attack - Alessandro Terruzzi, MD 
• Closing Remarks and Questions

For more information please visit the official event page.